GALMED PHARMACEUTICALS LTD. Payments to Acquire Equity Method Investments
GALMED PHARMACEUTICALS LTD. (GLMD) reported Payments to Acquire Equity Method Investments of $1.50 million for the 6-month period ending 2023-06-30, per its 6-K filed 2024-08-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2024-08-28
- 2023-06-30: Payments to Acquire Equity Method Investments 6 month $1.50M.
| Period end | Payments to Acquire Equity Method Investments 6 month |
|---|---|
| 2023-06-30 | $1.50M 6-K · filed 2024-08-28 |